Delivery Order SPE2DB22D3004-SPE2DB25FQE56
Award Date
4/8/25
Potential Completion Date
4/9/25
Potential Value
$9.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,366.55 Firm Fixed Price Delivery Order contract is for the supply of BIMZELX 160 MG/ML AUTOINJECTORML, with an ultimate completion date of October 25, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $23,016.42 firm-fixed-price delivery order is for the supply of BIMZELX 160 MG/ML AUTOINJECTORML, a pharmaceutical product. The contract has an ultimate completion date of August 9, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with government agencies, including a $999,999,999 IDC with the DLA Troop...
This federal contract award, valued at $8,389.19, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of BIMZELX 160 MG/ML AUTOINJECTORML, a medical product, with a completion date of March 14, 2025. The contract is a Firm Fixed Price arrangement, without any set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award, with an ID of SPE2DB20D2104|SPE2DB25FMKSN, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,405.92 Firm Fixed Price delivery order contract is for the supply of BIMZELX 160 MG/ML AUTOINJECTORML, a medical product, with a period of performance through March 11, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,544.73, is for the supply of BIMZELX 160 MG/ML AUTOINJECTORML, a medical product. This award is not a set-aside contract. The contract has an ultimate completion date of April 28, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $29,476.69, is for the delivery of BIMZELX 160 MG/ML AUTOINJECTORML, a pharmaceutical product. The contract is not set aside and has an ultimate completion date of June 9, 2025. Amerisourcebergen Drug Corp is a for-profit organization that holds a significant Indefinite...
This federal contract award, valued at $25,549.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication BIMZELX 160 MG/ML AUTOINJECTORML, with a performance period ending on May 2, 2025. The contract is a firm fixed-price agreement and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award, with an ID of SPE2DB20D2104|SPE2DB25FMGVG, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,802.33 firm-fixed-price delivery order covers the supply of BIMZELX 160 MG/ML AUTOINJECTORML, a medical product, to support federal healthcare programs. The contract is not designated as a set-aside and serves as a delivery order under AmerisourceBergen's existing...
This federal contract award, identified as SPE2DB22D3009|SPE2DB25FAR34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,052.04, is for the delivery of the drug BIMZELX 160 MG/ML AUTOINJECTORML. This is a Firm Fixed Price Delivery Order contract with a completion date of February 14, 2025. The contract does not have a set-aside designation, indicating open...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,020.88, is a delivery order for the medical product "ADBRY 300 MG/2 ML AUTOINJECTOR 2ML". The contract has an ultimate completion date of April 10, 2025 and is a firm fixed-price contract. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...